Rahaf M. Altahan: Diagnosis and Management of Factor XIII Deficiency
Rahaf M. Altahan, Consultant Hematopathologist at King Fahad Medical City – KFMC, shared a post on LinkedIn:
“I am delighted to share that my paper on Factor XIII deficiency has been published in Frontiers-Medicine FXIIID is up to 10x more prevalent in countries with high rates of consanguinity. Yet it is frequently missed!
Routine coagulation screening cannot detect low FXIII levels, since it acts downstream in the clotting cascade, after the clot is already formed.
Compounding this, relatively low FXIII levels can still maintain adequate hemostasis, which can delay recognition. Together, these factors make FXIIID one of the most underdiagnosed bleeding disorders in clinical practice.
The review covers the epidemiology, molecular biology, and diagnostic strategies (and their pitfalls), along with management approaches, including special clinical scenarios such as pregnancy, neonatal care, surgery, and anticoagulation.
I hope this serves as a useful resource for hematologists, hematopathologists, laboratory specialists, and clinicians who may encounter this often-overlooked condition.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke